{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Cancer Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203 China",
    "Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200433 China",
    "School of Pharmacy, Jinan University, Guangzhou, 510632 China",
    "Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400 China"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Yi Chen"
    },
    {
      "affs": [
        0
      ],
      "name": "Qiu-pei Liu"
    },
    {
      "affs": [
        2
      ],
      "name": "Si-jie Yang"
    },
    {
      "affs": [
        0
      ],
      "name": "Jian Ding"
    },
    {
      "affs": [
        2
      ],
      "name": "Xiao-yun Lu"
    },
    {
      "affs": [
        0,
        3
      ],
      "name": "Hua Xie"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6sx3xtb28h5pv.bib",
  "cited_by": 1,
  "doi": "10.1038/s41401-026-01855-0",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13720212/",
  "id": "6sx3xtb28h5pv",
  "issns": [
    "1671-4083",
    "1745-7254"
  ],
  "landing_url": "https://doi.org/10.1038/s41401-026-01855-0",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Review Article"
    ],
    [
      "openalex",
      "2740|Lung Cancer Treatments and Mutations"
    ]
  ],
  "openalex": "W7167692029",
  "pdf_url": null,
  "pmcid": "PMC13720212",
  "pmid": "42420595",
  "published": "2026-07-08",
  "publisher": "Nature Publishing Group",
  "ris": "https://research.draconitic.com/paper/6sx3xtb28h5pv.ris",
  "sources": [
    {
      "first_seen": "2026-11-02T12:24:02Z",
      "native_id": "PMC13720212",
      "source": "pmc",
      "url": "https://doi.org/10.1038/s41401-026-01855-0"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2740|Lung Cancer Treatments and Mutations",
      "subfield": "general"
    }
  ],
  "title": "Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance",
  "title_text": "Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance",
  "type": "peer-reviewed",
  "updated_at": "2026-11-03T12:21:08Z",
  "url": "https://research.draconitic.com/paper/6sx3xtb28h5pv",
  "venue": "Acta Pharmacologica Sinica",
  "versions": []
}